Regional variations in adverse event reporting rates and ACR responses in placebo/standard-of-care arms of rheumatoid arthritis trials

Volume: 59, Issue: 10, Pages: 3023 - 3031
Published: Mar 17, 2020
Abstract
Objective Clinical trials are increasingly globalized, and adverse event (AE) rates and treatment responses may differ by geographical region. This study assessed regional differences in AE reporting rates and ACR response rates (ACR20/50) in patients with RA who received placebo/standard-of-care treatment in clinical trials. Methods Patients from the placebo arms of 7 RA trials in the TransCelerate Biopharma Inc database were grouped into 5...
Paper Details
Title
Regional variations in adverse event reporting rates and ACR responses in placebo/standard-of-care arms of rheumatoid arthritis trials
Published Date
Mar 17, 2020
Volume
59
Issue
10
Pages
3023 - 3031
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.